QBI is developing an integrated translational pipeline designed to better connect basic discovery with therapeutic development. This evolving framework aims to align QBI’s academic research programs, affiliated companies, and foundation, helping to bridge longstanding gaps between academia and industry while supporting diversified, cross-sector funding. Early translational efforts emerging from this ecosystem include Rezo Therapeutics which grew out of QBI’s Cancer Cell Map Initiative.
